ProPhase Labs, Inc. · OTC:PRPH
ProPhase Labs — Investor Presentation (October 2020)
11 slides from ProPhase Labs's investor presentation, Oct 6, 2020
Slide 1: October 2020
NASDAQ: PRPH OCTOBER 2020
Slide 2: Forward Looking Statements
Forward Looking Statements _gProPhase This presentation contains forward-looking statements relating to the our strategy and business objectives. All statements other than statements of historical facts included in this presentation may be deemed to be forward-looking statements. You can identify fo
Slide 3: Corporate Overview
Corporate Overview ProPhase Labs (NASDAQ: PRPH) is a diversified medical science and technology company that develops, contract manufactures, and distributes Over-The- Counter (OTC) consumer healthcare products and dietary supplements. ProPhase Successful In-House TK Supplements® Brand: Created diet
Slide 4: Pharmaloz Manufacturing
Pharmaloz Manufacturing Ph l One of the Largest Lozenge pierre rea ee Manufacturers in the U.S. * Contract Manufacturing - 60,000 sq. ft. climate-controlled facility on 12 acres operating under FDA 21 CFR 210 & 211 guidelines provides the ability to offer products for diversified needs ¢ Private Lab
Slide 5: TK Supplements
ProPhase —@— “tikes TK Supplements® | 1K Supplements® is dedicated to promoting a better health, energy and sexual vitality. ¢ We offer a line of dietary supplement products under the TK Supplements® brand, including: — LEGENDZ XL®, for male sexual enhancement — TRIPLE EDGE XL®, a daily energy and s
Slide 6: TK Supplements Authorized Distribution Platform
TK Supplements ProPhase LABS - Authorized Distribution Platform Drug Channel: * Walgreens: Sept 2019 *CVS: Oct 2020 (Authorized BOTH Legendz XL AND Triple Edge XL) *Rite Aid: 2018, expanding to full distribution in Jan 2021 * Bartell Drug *Cardinal Health — Authorized in POG for certain independent
Slide 7: Growth Drivers
Growth Drivers COVID Testing & Lab Processing * Purchase and build out CLIA certified labs for processing * Longer term vision of COVID/influenza saliva- based test as well as various diagnostic testing * After six months of extensive due diligence, management has uncovered several exciting and time
Slide 8: Financials
Financials _gProPhase ¢ Restructured manufacturing operations to lower costs, contributing to an increase in gross margins. * Strong customer demand drove 100% quarter-over-quarter sales growth in Q2 2020. 3 Months 6 Months Ending June 30 Ending June 30 Sin millions 2020 2019 2020 2019 Total Revenue
Slide 9: Management
Management _gProPhase Ted Karkus - Chairman & CEO Ted Karkus is the CEO and Chairman of the Board of Directors of ProPhase Labs. He financed and advised ID Biomedical, a biotech/vaccine company, when it was valued at $25 million and near bankruptcy. He successfully persuaded the board of directors i
Slide 10: Key Takeaways
Key Takeaways Successful In-House TK Supplements® Brand: Created dietary supplements product line, sold at CVS, Walgreens, Walmart & more. One of the Leading Lozenge Contract Manufacturers in the U.S.: State-of-the-art lozenge manufacturer. Strong Revenue Growth: Restructured manufacturing operation
Slide 11: Contact
Contact Company Investor Relations Ted Karkus Chris Tyson Chairman & CEO Executive Vice President 621 .N. Shady Retreat Rd. MZ North America Doylestown, PA 18901 Direct: 949-491-8235 PRPH@mzgroup.us www.mzgroup.us ProPhase ee al LABS www.prophaselabs.com